Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term longitudinal study on swine VML model.
De Paolis F, Testa S, Guarnaccia G, Reggio A, Fornetti E, Cicciarelli F, Deodati R, Bernardini S, Peluso D, Baldi J, Biagini R, Bellisari FC, Izzo A, Sgalambro F, Arrigoni F, Rizzo F, Cannata S, Sciarra T, Fuoco C, Gargioli C. De Paolis F, et al. Among authors: testa s. Biol Direct. 2023 Jul 31;18(1):42. doi: 10.1186/s13062-023-00399-1. Biol Direct. 2023. PMID: 37518063 Free PMC article.
Corrigendum to "Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation" [International Journal of Cardiology 407 (2024) 132088].
Bernardini A, Bindini L, Antonucci E, Berteotti M, Giusti B, Testa S, Palareti G, Poli D, Frasconi P, Marcucci R. Bernardini A, et al. Among authors: testa s. Int J Cardiol. 2024 Jun 8:132226. doi: 10.1016/j.ijcard.2024.132226. Online ahead of print. Int J Cardiol. 2024. PMID: 38851912 No abstract available.
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY.
Palareti G, Testa S, Legnani C, Dellanoce C, Cini M, Paoletti O, Ciampa A, Antonucci E, Poli D, Morandini R, Tala M, Chiarugi P, Santoro RC, Iannone AM, De Candia E, Pignatelli P, Faioni EM, Chistolini A, Esteban MDP, Marietta M, Tripodi A, Tosetto A. Palareti G, et al. Among authors: testa s. Blood Adv. 2024 Jun 6:bloodadvances.2024013126. doi: 10.1182/bloodadvances.2024013126. Online ahead of print. Blood Adv. 2024. PMID: 38842448
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept.
Favi E, Cresseri D, Perego M, Ikehata M, Iesari S, Campise MR, Morello W, Testa S, Sioli V, Mattinzoli D, Longhi E, Del Gobbo A, Castellano G, Ferraresso M. Favi E, et al. Among authors: testa s. Clin Immunol. 2024 Jul;264:110240. doi: 10.1016/j.clim.2024.110240. Epub 2024 May 9. Clin Immunol. 2024. PMID: 38734036 Free article.
The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study.
Dorma MPF, Giuliani G, Guerra F, Santelli F, Esposito A, De Pastena M, Turri G, Pedrazzani C, Kauffmann EF, Boggi U, Solaini L, Ercolani G, Mastrangelo L, Jovine E, Di Franco G, Morelli L, Mazzola M, Ferrari G, Langella S, Ferrero A, La Mendola R, Abu Hilal M, Depalma N, D'Ugo S, Spampinato MG, Frisini M, Brolese A, Palaia R, Belli A, Cillara N, Deserra A, Cannavera A, Sagnotta A, Mancini S, Pinotti E, Montuori M, Coppola A, Di Benedetto F, Coratti A; COVID-AGICT Collaborative Group. Dorma MPF, et al. Surg Oncol. 2024 Jun;54:102081. doi: 10.1016/j.suronc.2024.102081. Epub 2024 Apr 26. Surg Oncol. 2024. PMID: 38729088
530 results